Research Paper Volume 16, Issue 1 pp 285—298

MAGE-A11 is a potential prognostic biomarker and immunotherapeutic target in gastric cancer

class="figure-viewer-img"

Figure 5. Heat map of differential genes in the high and low expression groups of MAGE-A11.